Tokenized stocks living on blockchains have crossed $1.6 billion in market capitalization. Injective, the layer 1 chain built specifically for trading and financial applications, has processed over $4.15 billion in related trading volume.
What’s actually happening here
Injective’s volume is being driven primarily through real-world asset perpetuals, which are essentially perpetual futures contracts that track the price of traditional stocks. Think of them as a way to get exposure to equities like Amazon or Google without ever touching a brokerage account, available 24 hours a day, seven days a week.
The platform first enabled decentralized tokenized stock trading back in 2020, initially listing stocks like Airbnb, Amazon, and Google. The $4.15 billion in year-to-date trading volume is not a cumulative lifetime number. This is 2026 activity alone.
The broader tokenized equities landscape
Ondo Finance, another major player in the space, has seen its tokenized stock total value locked surpass $1.17 billion. Ondo’s total trading volume has approached $20 billion.
What this means for investors
The competitive dynamics are worth watching closely. Injective’s $4.15 billion in volume and Ondo’s $20 billion represent two different approaches: Injective primarily through perpetual futures and Ondo through tokenized asset products with integrations across chains like Solana.
Tokenized equity products carry the standard smart contract and protocol risks, but they also introduce correlation with traditional markets. A sharp selloff in tech stocks doesn’t just stay in the Nasdaq anymore. It ripples directly into onchain positions tied to those same names.
Tokenized securities sit in a particularly interesting gray zone where crypto regulation meets securities law. How regulators in major markets choose to classify and oversee these products could dramatically alter the growth curve in either direction. A favorable framework could unlock institutional capital that’s currently sitting on the sidelines.
Leave a comment